Exosomes are extracellular nanovesicles naturally secreted by cells, especially mesenchymal stem cells (MSCs). They serve as biological messengers, carrying proteins, lipids, and genetic material (mRNA, miRNA) from one cell to another. Exosome therapy harnesses these bioactive vesicles for regenerative purposes. Because exosomes deliver the precise molecular instructions cells use to heal, they modulate immunity, promote cellular repair, and improve systemic communication between cells: reaching where conventional treatment can’t.
Explore our exosomes therapy programs
Research shows
Practical product identifiers and format details for professional review.
Content
10 lyophilised vials
Format
Vial
Also known as
Extracellular vesicles, MSC-derived exosomes
Exosomes function as an intercellular communication system by delivering molecular signals to recipient cells. Research explores their ability to influence repair pathways, shift macrophage polarisation from inflammatory M1 activity towards restorative M2 activity, support angiogenesis through VEGF-associated pathways, alter gene expression through miRNAs and transcriptional regulators, and reduce pro-fibrotic signalling and extracellular matrix deposition.
Based on published research and preclinical data. All benefits are documented under research-grade conditions.
Exosome signalling is studied in orthopaedic injuries, post-surgical recovery, and degenerative joint conditions such as osteoarthritis, with a focus on how cell-to-cell messages can support tissue repair.
Research investigates how exosomes may influence inflammatory pathways and macrophage polarisation, with potential relevance to chronic inflammation, autoimmune research, and post-viral fatigue models.
Dermatology and aesthetic research explores exosome-mediated collagen signalling, elasticity support, tissue remodelling, and wound-healing responses.
Because extracellular vesicles can cross the blood-brain barrier, they are being investigated in emerging research on cellular communication in neurodegenerative conditions, including Alzheimer's and Parkinson's disease.
Exosome preparations deliver bioactive signalling material without transplanting live cells. This cell-free format is studied as a lower-immunogenic alternative to live-cell approaches.
Explore selected publications and registered trials on Exosomes, with links to the original sources.
5 publications from the research library.
Evidence type
Publication and key finding
Source
Evidence type
Review
Research relevant to Exosomes
Publication and key finding
The study reports that this paper describes the application and mechanism whereby ADMSC-Exo-miRNA regulates wound healing.
Journal of materials chemistry. B
Evidence type
Review
Direct Exosomes evidence
Publication and key finding
The study reports that compared with ADSCs therapeutics, ADSCs-EXOs have highly stability and are easily stored.
Cell proliferation
Evidence type
Preclinical study
Direct Exosomes evidence
Publication and key finding
The study reports that we found the quality of oocytes was improved by HUCMSCs-exosomes.
Reproductive sciences (Thousand Oaks, Calif.)
Evidence type
Preclinical study
Direct Exosomes evidence
Publication and key finding
The study reports that this study tested the hypothesis that administration of exosomes derived from MSCs preconditioned with Mel gave best protection against RIRI as compared to therapy by MSCs or exosomes derived from non-preconditioned MSCs.
American journal of translational research
Evidence type
Preclinical study
Direct Exosomes evidence
Publication and key finding
The study reports that furthermore, the chemoattractive effects of CCL2 and CCL21 on inflammatory cells were inhibited by MSC-Exo.
Scientific reports
5 selected studies from the wider trial library, in the order chosen for this product.
NCT06319287
NCT05523011
NCT07372001
NCT06539273
NCT07281690
This public COA documents one selected production batch and is updated annually. It is not the COA for our latest available batch. Every batch has its own documentation, and partners can request the latest batch COA from our team.